“…It is also possible to allocate monoclonal antibodies by surface receptors which are guided action of monoclonal antibodies to CD markers, monoclonal antibodies to receptors IL, monoclonal antibodies to THF-α, monoclonal antibodies to molecules of cellular adhesion. To facilitate the recognition of the monoclonal antibodies it was observed that they all end in "mab", obtained from mice are "omab", chimeric antibodies are "ximab", humanized antibodies are "zumab" fully human are "umab" [21][22][23].…”